These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1540406)

  • 61. Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases.
    Grassi G; Dawson P; Guarnieri G; Kandolf R; Grassi M
    Curr Pharm Biotechnol; 2004 Aug; 5(4):369-86. PubMed ID: 15320768
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delivery of novel macromolecular drugs against HIV-1.
    Düzgünes N; Simões S; Konopka K; Rossi JJ; Pedroso de Lima MC
    Expert Opin Biol Ther; 2001 Nov; 1(6):949-70. PubMed ID: 11728227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Secondary structure in solution of two anti-HIV-1 hammerhead ribozymes as investigated by two-dimensional 1H 500 MHz NMR spectroscopy in water.
    Sarma RH; Sarma MH; Rein R; Shibata M; Setlik RS; Ornstein RL; Kazim AL; Cairo A; Tomasi TB
    FEBS Lett; 1995 Jan; 357(3):317-23. PubMed ID: 7835436
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing.
    Lange MJ; Sharma TK; Whatley AS; Landon LA; Tempesta MA; Johnson MC; Burke DH
    Mol Ther; 2012 Dec; 20(12):2304-14. PubMed ID: 22948672
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Designing ribozymes for the inhibition of gene expression.
    Bramlage B; Luzi E; Eckstein F
    Trends Biotechnol; 1998 Oct; 16(10):434-8. PubMed ID: 9807841
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antiviral and anticancer ribozymes.
    Poeschla E; Wong-Staal F
    Curr Opin Oncol; 1994 Nov; 6(6):601-6. PubMed ID: 7827172
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ribozymes: structure, function, and potential therapy for dominant genetic disorders.
    Grassi G; Marini JC
    Ann Med; 1996 Dec; 28(6):499-510. PubMed ID: 9017109
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic potential of ribozymes in haematological disorders.
    James HA
    Expert Opin Investig Drugs; 2000 May; 9(5):1009-20. PubMed ID: 11060723
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Exogenous application of ribozymes for inhibiting gene expression.
    Eckstein F
    Ciba Found Symp; 1997; 209():207-12; discussion 212-7. PubMed ID: 9383578
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.
    Bai Y; Gong H; Li H; Vu GP; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3222-7. PubMed ID: 21300908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic ribozymes: principles and applications.
    Rossi JJ
    BioDrugs; 1998 Jan; 9(1):1-10. PubMed ID: 18020552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy.
    Zaia JA; Chatterjee S; Wong KK; Elkins D; Taylor NR; Rossi JJ
    Ann N Y Acad Sci; 1992 Oct; 660():95-106. PubMed ID: 1340161
    [No Abstract]   [Full Text] [Related]  

  • 73. Repurposing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling of RNA.
    Ghaem Maghami M; Dey S; Lenz AK; Höbartner C
    Angew Chem Int Ed Engl; 2020 Jun; 59(24):9335-9339. PubMed ID: 32162405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antisense antivirals.
    Goodchild J
    Antisense Res Dev; 1991; 1(4):361-4. PubMed ID: 1821657
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The therapeutic potential of ribozymes.
    James HA; Gibson I
    Blood; 1998 Jan; 91(2):371-82. PubMed ID: 9427689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-viral delivery of ribozymes for cancer gene therapy.
    Kashani-Sabet M
    Expert Opin Biol Ther; 2004 Nov; 4(11):1749-55. PubMed ID: 15500403
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Approaches for the inhibition of human telomerase based on the use of peptide nucleic acids and hammerhead ribozymes.
    Zaffaroni N; Villa R; Pennati M; Folini M
    Mini Rev Med Chem; 2003 Feb; 3(1):51-60. PubMed ID: 12570854
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Self-cleaving ribozymes: substrate specificity and synthetic biology applications.
    Peng H; Latifi B; Müller S; Lupták A; Chen IA
    RSC Chem Biol; 2021 Oct; 2(5):1370-1383. PubMed ID: 34704043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function.
    Muotri AR; da Veiga Pereira L; dos Reis Vasques L; Menck CF
    Gene; 1999 Sep; 237(2):303-10. PubMed ID: 10521654
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gene-expressed RNA as a therapeutic: issues to consider, using ribozymes and small hairpin RNA as specific examples.
    Fanning GC; Symonds G
    Handb Exp Pharmacol; 2006; (173):289-303. PubMed ID: 16594621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.